임상 진단 시장 : 세계 산업 규모, 점유율, 동향, 기회, 예측 - 검사별, 제품별, 최종사용자별, 지역별, 경쟁별(2020-2030년)
Clinical Diagnostics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Test, By Product, By End User, By Region and Competition, 2020-2030F
상품코드:1878892
리서치사:TechSci Research
발행일:2025년 11월
페이지 정보:영문 189 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
한글목차
세계의 임상 진단 시장은 2024년에 822억 2,000만 달러로 평가되었으며, 2030년까지 CAGR 6.45%로 성장하여 1,196억 5,000만 달러에 달할 것으로 예측됩니다.
세계 임상 진단 시장은 질병의 발견, 진단, 모니터링 및 치료 방침을 결정하기 위해 생물학적 검체에 대해 수행되는 다양한 검사를 포함합니다. 이러한 성장은 주로 전 세계적으로 만성질환 및 감염성 질환의 증가, 고령화 인구의 증가, 예방의학 및 조기 질병 발견에 대한 인식이 높아짐에 따라 성장세를 보이고 있습니다.
시장 개요
예측 기간
2026-2030년
시장 규모 : 2024년
822억 2,000만 달러
시장 규모 : 2030년
1,196억 5,000만 달러
CAGR : 2025-2030년
6.45%
가장 빠르게 성장하는 부문
전혈구계산
최대 시장
북미
주요 시장 촉진요인
주요 시장 과제
주요 시장 동향
목차
제1장 개요
제2장 조사 방법
제3장 주요 요약
제4장 고객의 소리
제5장 세계의 임상 진단 시장 전망
시장 규모 및 예측
금액별
시장 점유율과 예측
검사별(지질 패널, 간 기능 검사, 신장 기능 검사, 전혈구계산, 전해질 검사, 감염증 검사, 기타 검사)
제품별(기기, 시약, 기타 제품)
최종사용자별(병원 검사실, 진단 검사실, POC(Point of Care) 검사, 기타 최종사용자)
지역별
기업별(2024)
시장 맵
제6장 북미의 임상 진단 시장 전망
시장 규모 및 예측
시장 점유율과 예측
북미 : 국가별 분석
미국
캐나다
멕시코
제7장 유럽의 임상 진단 시장 전망
시장 규모 및 예측
시장 점유율과 예측
유럽 : 국가별 분석
독일
프랑스
영국
이탈리아
스페인
제8장 아시아태평양의 임상 진단 시장 전망
시장 규모 및 예측
시장 점유율과 예측
아시아태평양 : 국가별 분석
중국
인도
일본
한국
호주
제9장 중동 및 아프리카의 임상 진단 시장 전망
시장 규모 및 예측
시장 점유율과 예측
중동 및 아프리카 : 국가별 분석
사우디아라비아
아랍에미리트
남아프리카공화국
제10장 남미의 임상 진단 시장 전망
시장 규모 및 예측
시장 점유율과 예측
남미 : 국가별 분석
브라질
콜롬비아
아르헨티나
제11장 시장 역학
성장 촉진요인
과제
제12장 시장 동향과 발전
인수합병
제품 출시
최근 동향
제13장 세계의 임상 진단 시장 : SWOT 분석
제14장 Porter's Five Forces 분석
업계내 경쟁
신규 참여의 가능성
공급업체의 능력
고객의 능력
대체품의 위협
제15장 경쟁 구도
Abbott Laboratories, Inc.
Becton, Dickinson and Company
Bio-Rad Laboratories, Inc.
Danaher Corporation
Siemens Healthineers AG
Hologic Inc.
Qiagen NV
F. Hoffmann-La Roche Ltd.
Thermo Fisher Scientific, Inc.
Quest Diagnostics, Inc.
제16장 전략적 제안
제17장 조사 회사 소개 및 면책사항
KSM
영문 목차
영문목차
The Global Clinical Diagnostics Market , valued at USD 82.22 Billion in 2024, is projected to experience a CAGR of 6.45% to reach USD 119.65 Billion by 2030. The global clinical diagnostics market encompasses a wide array of laboratory tests performed on biological samples to detect, diagnose, monitor, and guide the management of diseases. Its growth is primarily driven by the increasing worldwide prevalence of chronic and infectious diseases, an expanding aging population, and heightened awareness concerning preventative healthcare and early disease detection.
Market Overview
Forecast Period
2026-2030
Market Size 2024
USD 82.22 Billion
Market Size 2030
USD 119.65 Billion
CAGR 2025-2030
6.45%
Fastest Growing Segment
Complete Blood Count
Largest Market
North America
Key Market Drivers
The increasing prevalence of chronic and infectious diseases constitutes a primary driver for the global clinical diagnostics market. The growing burden of conditions like diabetes, cardiovascular diseases, and various respiratory and other infections necessitates consistent, accurate diagnostic testing for effective disease management, early detection, and public health surveillance. These health challenges generate continuous demand for both routine and specialized diagnostic panels, enabling providers to identify diseases at treatable stages and monitor therapy. For instance, according to the CDC, in November 2024, "2023-2024 Influenza Season Summary: Influenza Severity Assessment, Burden and Burden Prevented", influenza was associated with 40 million illnesses in the United States during the 2023-2024 season, highlighting a significant need for diagnostic tools. This persistent demand underpins the market's growth trajectory.
Key Market Challenges
The complex and evolving global regulatory landscape represents a significant impediment to the growth of the Global Clinical Diagnostics Market. Stringent and often divergent requirements for product approval and market access across various jurisdictions directly contribute to extended development timelines and elevated operational expenditures for manufacturers and innovators. This regulatory burden diverts substantial resources that could otherwise be allocated to research and development or market expansion activities.
For instance, according to MedTech Europe's 2024 Regulatory Survey, certification and maintenance costs for in vitro diagnostic (IVD) devices under new European regulations escalated by 100% or more compared to previous directives. This significant increase directly impacts profitability and the ability of companies to invest in new diagnostic technologies.
Key Market Trends
The decentralization of testing through point-of-care diagnostics significantly influences the market by enabling rapid results and improving patient access outside traditional laboratory settings. This shift supports immediate clinical decision-making across various healthcare environments. A July 2024 Eurostat report indicated that 35.0% of EU residents reported having a chronic health problem in 2023, underscoring the ongoing need for accessible diagnostic tools. This expansion is exemplified by Siemens Healthineers partnering with Carna Health in August 2025 to introduce point-of-care chronic kidney disease testing in emerging markets, integrating an AI-derived platform with existing diagnostics infrastructure for improved early detection. This trend drives demand for portable, user-friendly diagnostic devices.
Key Market Players
Abbott Laboratories, Inc.
Becton, Dickinson and Company
Bio-Rad Laboratories, Inc.
Danaher Corporation
Siemens Healthineers AG
Hologic Inc.
Qiagen NV
F. Hoffmann-La Roche Ltd.
Thermo Fisher Scientific, Inc.
Quest Diagnostics, Inc.
Report Scope:
In this report, the Global Clinical Diagnostics Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Clinical Diagnostics Market , By Test:
Lipid Panel
Liver Panel
Renal Panel
Complete Blood Count
Electrolyte Testing
Infectious Disease Testing
Other Tests
Clinical Diagnostics Market , By Product:
Instruments
Reagents
Other Products
Clinical Diagnostics Market , By End User:
Hospital Laboratory
Diagnostic Laboratory
Point-of-care Testing
Other End Users
Clinical Diagnostics Market , By Region:
North America
United States
Canada
Mexico
Europe
France
United Kingdom
Italy
Germany
Spain
Asia Pacific
China
India
Japan
Australia
South Korea
South America
Brazil
Argentina
Colombia
Middle East & Africa
South Africa
Saudi Arabia
UAE
Competitive Landscape
Company Profiles: Detailed analysis of the major companies presents in the Global Clinical Diagnostics Market .
Available Customizations:
Global Clinical Diagnostics Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
Detailed analysis and profiling of additional market players (up to five).
Table of Contents
1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5. Global Clinical Diagnostics Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Test (Lipid Panel, Liver Panel, Renal Panel, Complete Blood Count, Electrolyte Testing, Infectious Disease Testing, Other Tests)
5.2.2. By Product (Instruments, Reagents, Other Products)
5.2.3. By End User (Hospital Laboratory, Diagnostic Laboratory, Point-of-care Testing, Other End Users)
5.2.4. By Region
5.2.5. By Company (2024)
5.3. Market Map
6. North America Clinical Diagnostics Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Test
6.2.2. By Product
6.2.3. By End User
6.2.4. By Country
6.3. North America: Country Analysis
6.3.1. United States Clinical Diagnostics Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Test
6.3.1.2.2. By Product
6.3.1.2.3. By End User
6.3.2. Canada Clinical Diagnostics Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Test
6.3.2.2.2. By Product
6.3.2.2.3. By End User
6.3.3. Mexico Clinical Diagnostics Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Test
6.3.3.2.2. By Product
6.3.3.2.3. By End User
7. Europe Clinical Diagnostics Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Test
7.2.2. By Product
7.2.3. By End User
7.2.4. By Country
7.3. Europe: Country Analysis
7.3.1. Germany Clinical Diagnostics Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Test
7.3.1.2.2. By Product
7.3.1.2.3. By End User
7.3.2. France Clinical Diagnostics Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Test
7.3.2.2.2. By Product
7.3.2.2.3. By End User
7.3.3. United Kingdom Clinical Diagnostics Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Test
7.3.3.2.2. By Product
7.3.3.2.3. By End User
7.3.4. Italy Clinical Diagnostics Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Test
7.3.4.2.2. By Product
7.3.4.2.3. By End User
7.3.5. Spain Clinical Diagnostics Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Test
7.3.5.2.2. By Product
7.3.5.2.3. By End User
8. Asia Pacific Clinical Diagnostics Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Test
8.2.2. By Product
8.2.3. By End User
8.2.4. By Country
8.3. Asia Pacific: Country Analysis
8.3.1. China Clinical Diagnostics Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Test
8.3.1.2.2. By Product
8.3.1.2.3. By End User
8.3.2. India Clinical Diagnostics Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Test
8.3.2.2.2. By Product
8.3.2.2.3. By End User
8.3.3. Japan Clinical Diagnostics Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Test
8.3.3.2.2. By Product
8.3.3.2.3. By End User
8.3.4. South Korea Clinical Diagnostics Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Test
8.3.4.2.2. By Product
8.3.4.2.3. By End User
8.3.5. Australia Clinical Diagnostics Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Test
8.3.5.2.2. By Product
8.3.5.2.3. By End User
9. Middle East & Africa Clinical Diagnostics Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Test
9.2.2. By Product
9.2.3. By End User
9.2.4. By Country
9.3. Middle East & Africa: Country Analysis
9.3.1. Saudi Arabia Clinical Diagnostics Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Test
9.3.1.2.2. By Product
9.3.1.2.3. By End User
9.3.2. UAE Clinical Diagnostics Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Test
9.3.2.2.2. By Product
9.3.2.2.3. By End User
9.3.3. South Africa Clinical Diagnostics Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Test
9.3.3.2.2. By Product
9.3.3.2.3. By End User
10. South America Clinical Diagnostics Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Test
10.2.2. By Product
10.2.3. By End User
10.2.4. By Country
10.3. South America: Country Analysis
10.3.1. Brazil Clinical Diagnostics Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Test
10.3.1.2.2. By Product
10.3.1.2.3. By End User
10.3.2. Colombia Clinical Diagnostics Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Test
10.3.2.2.2. By Product
10.3.2.2.3. By End User
10.3.3. Argentina Clinical Diagnostics Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Test
10.3.3.2.2. By Product
10.3.3.2.3. By End User
11. Market Dynamics
11.1. Drivers
11.2. Challenges
12. Market Trends & Developments
12.1. Merger & Acquisition (If Any)
12.2. Product Launches (If Any)
12.3. Recent Developments
13. Global Clinical Diagnostics Market : SWOT Analysis
